On the public citation graph
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
Inferred edges come from two machine sources: sweeps of open repository
metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is
labelled with the one it came from. Neither is a complete citation index — absence here is not
evidence of absence.
1 of the 42 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1210/jc.2014-2739 (notice 2015-05-01).
Dataset join, best-effort; this page does not check the publisher record.
Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0);
dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated
CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/hep.23116openalex-snapshotImportance of Changes in Adipose Tissue Insulin Resistance to Histological Response During Thiazolidinedione Treatment of Patients with Nonalcoholic Steatohepatitis†
inferredcites →https://doi.org/10.1002/hep.25539openalex-snapshotEffect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.26988openalex-snapshotRelationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/hep.27395openalex-snapshotThe role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.cgh.2015.01.027openalex-snapshotAssociation Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1038/ajg.2010.18openalex-snapshotNonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
inferredcites →https://doi.org/10.1053/j.gastro.2010.09.038openalex-snapshotPrevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
inferredcites →https://doi.org/10.1111/liv.12840openalex-snapshotClinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients
inferredcites →https://doi.org/10.1172/jci114142openalex-snapshotGlucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
inferredcites →https://doi.org/10.1210/jc.2014-2739openalex-snapshotWITHDRAWN: High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels (article published in final form as 10.1210/jc.2015-1966)
inferredcites →https://doi.org/10.1210/jc.2015-1966openalex-snapshotHigh Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
inferredcites →https://doi.org/10.2337/db10-1806openalex-snapshotLiver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women
inferredcites →https://doi.org/10.2337/dc06-2247openalex-snapshotPrevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
inferredcites →https://doi.org/10.2337/dc10-2229openalex-snapshotPrevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
inferredcites →https://doi.org/10.2337/dc11-1849openalex-snapshotPrevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
inferredcites →https://doi.org/10.2337/diabetes.49.5.749openalex-snapshotHepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
inferredcites →https://doi.org/10.2337/diabetes.52.10.2461openalex-snapshotA Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4840179openalex-extractedThe Pan-PPAR Agonist Lanifibranor Reverses Metabolic Dysfunction in People with Type 2 Diabetes and MASLD: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial
inferred← citeshttps://doi.org/10.2139/ssrn.4841348openalex-extractedZuogui-Jiangtang-Qinggan Formula Alleviated Hepatic Steatosis in Diabetes by Improving Energy and Bile Acid Metabolism: Based on Multi-Omics Integration Studies
inferred← citeshttps://doi.org/10.1002/edm2.163openalex-snapshotGlucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review
inferred← citeshttps://doi.org/10.1002/hep.28985openalex-snapshotMetabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.eprac.2022.03.010openalex-snapshotAmerican Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
inferred← citeshttps://doi.org/10.1016/j.jff.2023.105879openalex-snapshotIntegrating network analysis and experimental validation to reveal the mechanism of pinocembrin in alleviating high glucose and free fatty acid-induced lipid accumulation in HepG2 cells
inferred← citeshttps://doi.org/10.1080/13543784.2020.1715940openalex-snapshotNASH (nonalcoholic steatohepatitis), diabetes, and macrovascular disease: multiple chronic conditions and a potential treatment at the metabolic root
inferred← citeshttps://doi.org/10.1089/met.2022.0105openalex-snapshotSerum C1q/TNF-Related Protein 4 Levels are Associated with Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
inferred← citeshttps://doi.org/10.1097/md.0000000000023506openalex-snapshotDisease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
inferred← citeshttps://doi.org/10.1097/meg.0000000000002767openalex-snapshotMetabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease
inferred← citeshttps://doi.org/10.1111/dom.12744openalex-snapshotBasal insulin peglispro: Overview of a novel long‐acting insulin with reduced peripheral effect resulting in a hepato‐preferential action
inferred← citeshttps://doi.org/10.1111/dom.12751openalex-snapshotDifferent effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes
inferred← citeshttps://doi.org/10.1111/dom.13584openalex-snapshotEffect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1111/dom.70553openalex-snapshotMetabolic liver disease: A summary of major guidelines and identifying opportunities to improve future guidelines
inferred← citeshttps://doi.org/10.1111/jdi.14066openalex-snapshotAssociation between hemoglobin glycation index and non‐alcoholic fatty liver disease in the patients with type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1111/jphp.12705openalex-snapshotInfluence of hyperglycemia on liver inflammatory conditions in the early phase of non-alcoholic fatty liver disease in mice
inferred← citeshttps://doi.org/10.1136/bmjdrc-2020-001990openalex-snapshotComparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial
inferred← citeshttps://doi.org/10.1152/ajpendo.00294.2023openalex-snapshotMetabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations
inferred← citeshttps://doi.org/10.1155/2023/6603522openalex-snapshotRhinacanthin C Ameliorates Insulin Resistance and Lipid Accumulation in NAFLD Mice via the AMPK/SIRT1 and SREBP‐1c/FAS/ACC Signaling Pathways
inferred← citeshttps://doi.org/10.1159/000520419openalex-snapshotEffects of Weight Loss on Adipose and Muscular Neuropilin 1 mRNA Expression in Obesity: Potential Implication in SARS-CoV-2 Infections?
inferred← citeshttps://doi.org/10.1186/s12872-025-05137-1openalex-snapshotAssociation of weight-adjusted waist index with all-cause and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease: a national population-based cohort study
inferred← citeshttps://doi.org/10.1186/s12876-022-02550-0openalex-snapshotAssociation between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12916-016-0638-yopenalex-snapshotNo effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
inferred← citeshttps://doi.org/10.1186/s12933-022-01691-6openalex-snapshotThe association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study
inferred← citeshttps://doi.org/10.1186/s12944-020-01421-5openalex-snapshotAssociation between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study
inferred← citeshttps://doi.org/10.1186/s13578-022-00836-0openalex-snapshotNovel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
inferred← citeshttps://doi.org/10.1194/jlr.m068395openalex-snapshotNicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S]
inferred← citeshttps://doi.org/10.1210/jc.2019-00970openalex-snapshotLetter to the Editor: “Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content“
inferred← citeshttps://doi.org/10.14740/jem937openalex-snapshotEpidemiology of Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus and Effects of Antiglycemic Therapy on Liver Fibrosis: A Retrospective Study
inferred← citeshttps://doi.org/10.1530/eje-18-0009openalex-snapshotMANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass
inferred← citeshttps://doi.org/10.2337/dc17-1349openalex-snapshotClinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients
inferred← citeshttps://doi.org/10.2337/dci24-0094openalex-snapshotMetabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
inferred← citeshttps://doi.org/10.2337/dsi23-0013openalex-snapshotRole of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care
inferred← citeshttps://doi.org/10.32469/10355/93980openalex-snapshotLifestyle treatment in the regression of NASH: insulin resistance, lipid synthesis, and methodological innovation
inferred← citeshttps://doi.org/10.3390/children11030275openalex-snapshotGlucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)
inferred← citeshttps://doi.org/10.3390/ijms222011128openalex-snapshotThe Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/jcm14082750openalex-snapshotMetabolic Syndrome and Liver Disease: Re-Appraisal of Screening, Diagnosis, and Treatment Through the Paradigm Shift from NAFLD to MASLD
inferred← citeshttps://doi.org/10.3390/metabo13050650openalex-snapshotDietary Coated Sodium Butyrate Ameliorates Hepatic Lipid Accumulation and Inflammation via Enhancing Antioxidative Function in Post-Peaking Laying Hens
inferred← citeshttps://doi.org/10.3390/nu14245339openalex-snapshotAssociation between Diet Quality and Index of Non-Alcoholic Steatohepatitis in a Large Population of People with Type 2 Diabetes: Data from the TOSCA.IT Study
inferred← citeshttps://doi.org/10.3390/ph19081283openalex-snapshotExploring the Molecular Mechanism of Cinnamaldehyde Intervening in Ochratoxin A-Induced Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Comorbidity: An Integrated Approach Based on Network Pharmacology, Network Toxicology and Molecular Docking
inferred← citeshttps://doi.org/10.3748/wjg.119898openalex-snapshotInterplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease
inferred← citeshttps://doi.org/10.3748/wjg.v22.i44.9674openalex-snapshotFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
inferred← citeshttps://doi.org/10.3892/etm.2017.5400openalex-snapshotResveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1
inferred← citeshttps://doi.org/10.3892/ijmm.2018.3702openalex-snapshotHistone modifications in fatty acid synthase modulated by carbohydrate responsive element binding protein are associated with non‑alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.3892/ijmm.2021.4947openalex-snapshotRole of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review)
inferred← citeshttps://doi.org/10.5009/gnl20367openalex-snapshotEffects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels
inferred← citeshttps://doi.org/10.5114/aoms/150639openalex-snapshotNon-alcoholic Fatty Liver Disease, Metabolic syndrome, and Type 2 diabetes mellitus: Where do we stand today?
inferred← citeshttps://doi.org/10.6084/m9.figshare.26550982openalex-snapshotAdditional file 1 of The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study
inferred← citeshttps://doi.org/10.7150/ijms.62010openalex-snapshotAssociation of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes
inferred← citeshttps://doi.org/10.7326/m15-1774openalex-snapshotLong-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID:
icsacinstitute.org/submit.